Peters-plus syndrome

From WikiMD's Medical Encyclopedia

(Redirected from Krause-Kivlin syndrome)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Peters-plus syndrome
Synonyms Krause-Kivlin syndrome
Pronounce
Specialty Medical genetics
Symptoms Corneal opacity, short stature, developmental delay, cleft lip and palate, dysmorphic features
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Mutations in the B3GALTL gene
Risks Family history of the condition
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis Peters anomaly, Axenfeld-Rieger syndrome
Prevention N/A
Treatment Symptomatic and supportive care
Medication N/A
Prognosis Variable, depending on severity
Frequency Rare
Deaths N/A


Peters Plus Syndrome[edit]

Peters Plus Syndrome is a rare genetic disorder characterized by a combination of ocular, craniofacial, and skeletal abnormalities. It is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome.

Clinical Features[edit]

Peters Plus Syndrome is primarily identified by the presence of Peters anomaly, which involves defects in the anterior segment of the eye, leading to corneal opacity and potential glaucoma. Other ocular features may include microphthalmia and cataracts. In addition to ocular abnormalities, individuals with Peters Plus Syndrome often exhibit distinctive craniofacial features such as a prominent forehead, a broad nasal bridge, and a long philtrum. Skeletal abnormalities may include short stature and brachydactyly.

Genetic Basis[edit]

The syndrome is caused by mutations in the B3GALTL gene, which is located on chromosome 13. This gene is responsible for encoding an enzyme involved in the glycosylation of proteins, a process crucial for normal development.

Diagnosis[edit]

Diagnosis of Peters Plus Syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the B3GALTL gene. Prenatal diagnosis is possible if the genetic mutation is known in the family.

Management[edit]

Management of Peters Plus Syndrome is symptomatic and supportive. Ophthalmologic interventions may be necessary to address vision problems, and regular monitoring for glaucoma is recommended. Early intervention and special education services can help address developmental delays.

See also[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.